3751 - 3775 of 7877 Results
Title
Year
-
OPENTitle: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e28End Page: e28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123Best OA location URL: https://doi.org/10.1101/2020.05.07.20072728Citation Count: 7
- Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE2020OPENTitle: Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBEJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 5Start Page: 309End Page: 323Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2020-0021Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/nmt-2020-0021Citation Count: 40
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
- Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers2020OPENTitle: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000010863Best OA location URL: https://n.neurology.org/content/neurology/95/24/e3428.full.pdfCitation Count: 45
-
OPENTitle: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1785End Page: 1795Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-020-00965-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00965-9.pdfCitation Count: 15
-
OPENTitle: Body-first versus brain-first biological subtyping of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2871End Page: 2873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa293Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2871/35939469/awaa293.pdfCitation Count: 17
- Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) study2020RESTRICTEDTitle: Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.312Citation Count: 0
- Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease2020OPENTitle: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 171End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28319Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28319Citation Count: 3
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis2020RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49
- Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder2020OPENTitle: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 235End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28318Best OA location URL: http://escholarship.mcgill.ca/downloads/fb494f269Citation Count: 12
- Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments2020RESTRICTEDTitle: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1681End Page: 1693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00914-6.pdfCitation Count: 58
- Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)2020RESTRICTEDTitle: Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e88End Page: e89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.322Citation Count: 0
-
OPENTitle: Differences in the Presentation and Progression of Parkinson's Disease by SexJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 106End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28312Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/235622/235622.pdfCitation Count: 61
-
RESTRICTEDTitle: Dopamine-mediated improvements in dynamic balance control in Parkinson’s diseaseJournal Name: Gait & PosturePublisher: Elsevier BVVol: 82Issue #:Start Page: 68End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132Citation Count: 7
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27
-
RESTRICTEDTitle: Evaluation of motor response inhibition in Parkinson's Disease and Alzheimer's DiseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.314Citation Count: 0
-
RESTRICTEDTitle: Exploring the clinical burden of OFF periods in Parkinson diseaseJournal Name: The American Journal of Managed CarePublisher: Managed Care and Healthcare Communications, LLCVol: 26Issue #: Suppl 12Start Page: S255End Page: S264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.37765/ajmc.2020.88517Citation Count: 11
- Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's disease2020RESTRICTEDTitle: Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e85End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.311Citation Count: 2
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
-
OPENTitle: If LRRK2 Set the Fire, Can Nonsteroidal Anti‐inflammatory Drugs Wet the Flames?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1727End Page: 1730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28240Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28240Citation Count: 4
- Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance2020RESTRICTEDTitle: Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder allianceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.325Citation Count: 0
-
RESTRICTEDTitle: Impact of OFF periods on aspects of employment for people with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.323Citation Count: 1
- Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyond2020OPENTitle: Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyondJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 135Issue #: 2Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2020.6.jns20617Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/aop/article-10.3171-2020.6.JNS20617/article-10.3171-2020.6.JNS20617.pdfCitation Count: 10
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15